< Back to latest news & events

News

KTN Microbiome Strategic Roadmap

February 2021

Event date: 29th January 2021

KTN Microbiome Strategic Roadmap is now live. The roadmap reviews the landscape of microbiome science and innovation within the UK. The main objective of this document is to raise the visibility of the UK’s world leading microbiome science and enable translation of this science to benefit academic institutions, start-ups, SMEs and larger established companies.

It is a collaborative effort of 74 leading academic and industry scientists, including HGF Partner Craig Thomson as author, supported with contribution from Michelle Davies and Dr Lauris Kemp.

There are 12 distinct sections within the report, which summarise the current state of microbiome research, business and growth opportunities within each sector:

  • Intestinal Microbiome Transfer
  • Live Biotherapeutic Products & other Therapeutic Modalities
  • Personal Care & Hygiene
  • Nutrition & Wellbeing
  • Animal Health & Nutrition
  • AgriFood & Nutrition – Crop & Soil Health
  • Regulatory
  • Manufacturing
  • Biobanking
  • Enabling Technologies
  • Diagnostics
  • Intellectual property

Download the report here

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

T 1847/22: Procedural considerations in appeal: Re-ordering of requests and the impact on admissibility

Background This case concerned EP 3 085 344 B1, which relates to a wound pad, a self-adhesive member comprising a wound pad. The patent was opposed by two opponents. During …

Read article

Regulation of NGT plants in Europe- Polish Presidency proposes an alternative solution to the Patent ban

In the latest development on the new proposed legislation for the regulation of NGT (gene-edited) plants in the EU, the Polish Presidency have proposed an amendment which removes the proposed …

Read article

T 0295/22: EPO Technical Board of Appeal relies on “bonus effect” case law to find Amgen’s patent to orally administered apremilast lacking in inventive step

This case concerned Amgen’s European patent no. 2962690 for apremilast, a drug sold under the brand name Otezla®, licensed for the treatment of e.g., psoriasis and psoriatic arthritis.  The patent …

Read article
Event - 18th March 2025

Salzburg Seminar: Pitfalls in trade mark practice - What can be protected as a trade mark?

The registration of trade marks is a central component of trade mark protection – but which signs can actually be protected? In recent years, the national trade mark offices and …

Event details

Can the Chancellor’s so-called “Europe’s Silicon Valley” really replicate the innovative activity of its namesake?

The Chancellor of the UK, Rachel Reeves, recently unveiled plans to deliver an Oxford-Cambridge growth corridor that promises to boost the UK economy by up to £78 billion by 2035.  …

Read article

UPC’s CFI (Milan) extends deadline to file defence to infringement claim to align with parallel EPO appeal proceedings

Dainese S.p.A. v. Alpinestars S.p.A. & ors. UPC_CFI_472/2024 – Milan Local Division (Perrotti, Zana, Klein, Ashley) – 15 January 2025 The Milan Local Division granted a defendant’s request for an …

Read article